Drug reference
satranidazole
Nitroimidazole · Antiamoebic, Antiprotozoal
NitroimidazoleAntiamoebic, Antiprotozoal
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Not yet extracted
Indications
AmoebiasisGiardiasisTrichomoniasis
Dosing
- Adult
- For amoebiasis: 300 mg BD for 3–5 days. For giardiasis and trichomoniasis: 600 mg single dose.
Pharmacokinetics
Half-life
14 hr.
Side effects
Common
claimed better tolerability (no nausea, vomiting or metallic taste)
Serious
- absence of neurological reactions
- absence of disulfiram-like reactions
- does not produce acetamide metabolite (weak carcinogen)
Other Nitroimidazole drugs
Ask House about satranidazole
Continue into a citation-backed clinical answer with the drug context already attached.
Textbook-sourced·Sources: KD Tripathi 7e·Updated: 2026-05-10